Global epidemiology of atrial fibrillation (Q35223184)

7 August 2017

Global epidemiology of atrial fibrillation (English)

1 reference

Erratum: Global epidemiology of atrial fibrillation

7 August 2017

0 references

1 reference

corrigendum / erratum

1 reference

10.1038/NRCARDIO.2016.114

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NRCARDIO.2016.114

3

Emelia J Benjamin

0 references

Gene F Kwan

object named as

Gene F Kwan

series ordinal

2

0 references

author name string

Faisal Rahman

series ordinal

1

1 reference

PubMed ID

25113750

7 August 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

Nature Reviews Cardiology

7 August 2017

1 reference

7 August 2017

11

1 reference

7 August 2017

639-654

1 reference

7 August 2017

11

1 reference

REPORT CXIX. AURICULAR FIBRILLATION: A COMMON CLINICAL CONDITION

7 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation prevalence revisited.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Screening to identify unknown atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and the risk of myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Coronary ischemic events after first atrial fibrillation: risk and survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Increasing prevalence of atrial fibrillation and flutter in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Stroke prevention in atrial fibrillation--an Asian stroke perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Rheumatic heart disease in rural south India: A clinico-observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

European ancestry as a risk factor for atrial fibrillation in African Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Genome-wide association studies of atrial fibrillation: past, present, and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

African american race and prevalence of atrial fibrillation:a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incident atrial fibrillation among Asians, Hispanics, blacks, and whites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Ethnic differences in atrial fibrillation identified using implanted cardiac devices.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of electrocardiographic findings in elderly individuals: the Sao Paulo aging & health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Strikingly low prevalence of atrial fibrillation in elderly Tanzanians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Epidemiology of valvular heart disease in the adult

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Secular trends, treatments, and outcomes of Middle Eastern Arab and South Asian patients hospitalized with atrial fibrillation: insights from a 20-year registry in Qatar (1991-2010).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Global burden of obesity in 2005 and projections to 2030.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Obesity and the Risk of New-Onset Atrial Fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and obesity--results of a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Association of obesity and atrial fibrillation among middle-aged and elderly Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk of new-onset atrial fibrillation in relation to body mass index

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People's Hospital of Peking University

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Pulse pressure and risk of new-onset atrial fibrillation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and death after myocardial infarction: a community study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Epidemiologic features of chronic atrial fibrillation: the Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Saudi Atrial Fibrillation Survey: national, observational, cross-sectional survey evaluating atrial fibrillation management and the cardiovascular risk profile of patients with atrial fibrillation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation in a tertiary care institute - a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Thyroid status, cardiovascular risk, and mortality in older adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Alcohol consumption and risk of atrial fibrillation: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Inflammation as a risk factor for atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Relation of vigorous exercise to risk of atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Familial aggregation of atrial fibrillation in Iceland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Familial aggregation of atrial fibrillation: a study in Danish twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

High familial risk of atrial fibrillation/atrial flutter in multiplex families: a nationwide family study in Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Meta-analysis identifies six new susceptibility loci for atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Validation of Clinical Classification Schemes for Predicting Stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk assessment for incident heart failure in individuals with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and dementia: results from the Sao Paulo ageing & health study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and cognitive decline: a longitudinal cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Relationship between CHA(2)DS(2)-VASc scores and ischemic stroke/cardiovascular events in Japanese patients with paroxysmal atrial fibrillation not receiving anticoagulant therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Association of atrial fibrillation with mortality and disability after ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Racial-ethnic differences in stroke risk factors and subtypes: results of a prospective hospital-based registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Comparison of ischemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Electrocardiographic assessment of coronary artery disease and stroke risk factors in rural and urban Tanzania: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Acute treatment and long-term management of stroke in developing countries.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

CYP2C9 and VKORC1 polymorphisms are differently distributed in the Brazilian population according to self-declared ethnicity or genetic ancestry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A pharmacogenetic versus a clinical algorithm for warfarin dosing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Stroke severity in atrial fibrillation. The Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: A prospective hospital-based study in Asia. Asian Acute Stroke Advisory Panel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The impact factors on the cost and length of stay among acute ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Characteristics, Treatment and Outcome of Ischemic Stroke with Atrial Fibrillation in a Chinese Hospital-Based Stroke Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Impact of atrial fibrillation on stroke-related healthcare costs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Cognitive impairment associated with atrial fibrillation: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incident atrial fibrillation and mortality in older adults with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and mortality in heart failure: a community study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and the risk of death in patients with heart failure: a literature-based meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation as a cause of death increased steeply in England between 1995 and 2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A comparison of rate control and rhythm control in patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation in mainland China: epidemiology and current management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Epidemiology, risk factors for stroke, and management of atrial fibrillation in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Cardiac electrophysiology in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incidence of chronic atrial fibrillation in general practice and its treatment pattern

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Digoxin use is associated with increased risk of stroke in patients with non-valvular atrial fibrillation--a nationwide population-based cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Complications of catheter ablation of atrial fibrillation: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf SAFE registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Trends in risk factor prevalence and management before first stroke: data from the South London Stroke Register 1995-2011.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Ethnicity and stroke risk in patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Improving cardiovascular disease management in Australia: NPS MedicineWise.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevalence and clinical characteristics of patients with atrial fibrillation: analysis of 20,000 cases in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Warfarin use in nursing home residents: results from the 2004 national nursing home survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk of falls and major bleeds in patients on oral anticoagulation therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Adapting clinical guidelines to take account of multimorbidity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

National trends in oral anticoagulant use in the United States, 2007 to 2011

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Risk factors between patients with lone and non-lone atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Characteristics of patients with venous thromboembolism and atrial fibrillation in Venezuela

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Variations between countries in outcome after stroke in the International Stroke Trial (IST)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Atrial fibrillation detected after acute ischemic stroke: evidence supporting the neurogenic hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Population-attributable risks for ischemic stroke in a community in South Brazil: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Ischemic stroke in Jordan 2000 to 2002: a two-year, hospital-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Stroke risk factors, subtypes, and 30-day case fatality in Abuja, Nigeria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Holter monitoring in the diagnosis of stroke mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Ethnic variations in risk factor profile, pattern and recurrence of non-cardioembolic ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Stroke in Qatar: a first prospective hospital-based study of acute stroke.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.118

Real-time ECG monitoring and arrhythmia detection using Android-based mobile devices.

31 March 2020

1 reference

12 December 2020

Racial/ethnic differences in the prevalence of atrial fibrillation among older adults--a cross-sectional study

1 reference

12 December 2020

Prevalence of atrial fibrillation in a primary health care centre in Fars Province, Islamic Republic of Iran.

1 reference

12 December 2020

The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit

1 reference

12 December 2020

Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank.

1 reference

12 December 2020

Retrospective analysis of stroke and its risk factors at Nepal Medical College Teaching Hospital

1 reference

12 December 2020

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

1 reference

12 December 2020

Stroke at moderate altitude.

1 reference

12 December 2020

Electrocardiographic abnormalities in patients with heart failure.

1 reference

12 December 2020

Prevalence of cardiac arrhythmias in Thai community

1 reference

12 December 2020

Atrial fibrillation and embolic complications.

1 reference

12 December 2020

Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?

1 reference

12 December 2020

[Atrial fibrillation prevalence and treatment with oral anticoagulation in patients with permanent pacemakers]

1 reference

12 December 2020

Electrocardiographic manifestations of healthy residents of a tribal Himalayan village

1 reference

12 December 2020

An electrocardiographic survey of elderly Thai people in the rural community

1 reference

12 December 2020

[Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults]

1 reference

12 December 2020

A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project

1 reference

12 December 2020

Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation.

1 reference

12 December 2020

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

12 December 2020

Prevalence of asymptomatic atrial fibrillation in malaysian patients with hypertension

1 reference

12 December 2020

REPORT CXIX. AURICULAR FIBRILLATION: A COMMON CLINICAL CONDITION.

1 reference

12 December 2020

Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up

1 reference

12 December 2020

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation

1 reference

12 December 2020

10.1038/NRCARDIO.2014.118

Identifiers

DOI

1 reference

release_uylcz6eg7jclzarkes6hg2f3ty

7 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uylcz6eg7jclzarkes6hg2f3ty

24 November 2022

mapped directly with Wikidata item

PubMed ID

25113750

1 reference

PubMed ID

25113750